These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 417345)

  • 41. Use of 14C-antipyrine for estimation of rhesus monkey eye blood flow.
    Kollaritis CR; Goldman H; Murphy S; Kollarits FJ
    Invest Ophthalmol Vis Sci; 1976 Sep; 15(9):740-5. PubMed ID: 822711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective body water half-life and total body water in rhesus and cynomolgus monkeys.
    Azar E; Shaw ST
    Can J Physiol Pharmacol; 1975 Oct; 53(5):935-9. PubMed ID: 811339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secondary thrombocytopenia following phenobarbital treatments in a rhesus monkey (Macaca mulatta).
    Ferguson PW; Anderson JH; Krieger RI
    Lab Anim Sci; 1979 Feb; 29(1):94-6. PubMed ID: 108473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-lasting enhancement of CYP activity after discontinuation of repeated administration of phenobarbital in dogs.
    Fukunaga K; Saito M; Matsuo E; Muto M; Mishima K; Fujiwara M; Orito K
    Res Vet Sci; 2009 Dec; 87(3):455-7. PubMed ID: 19406444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipyrine estimations in the rabbit using gas--liquid chromatography: a reliable method for studying factors affecting oxidative drug metabolism.
    Chambers DM; Jefferson GC
    J Pharmacol Methods; 1981 Jan; 5(1):59-66. PubMed ID: 7265986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.
    Wolff T; Deml E; Wanders H
    Drug Metab Dispos; 1979; 7(5):301-5. PubMed ID: 40770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.
    Vesell ES; Passananti GT; Aurori KC
    Pharmacology; 1975; 13(2):101-11. PubMed ID: 49899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 50. Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram.
    Freundt KJ
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):323-30. PubMed ID: 669879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits.
    Statland BE; Astrup P; Black CH; Oxholm E
    Pharmacology; 1973; 10(6):329-37. PubMed ID: 4784365
    [No Abstract]   [Full Text] [Related]  

  • 52. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.
    Krishnaswamy K; Naidu AN
    Br Med J; 1977 Feb; 1(6060):538-40. PubMed ID: 843795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
    Schellens JH; van der Wart JH; Brugman M; Breimer DD
    J Pharmacol Exp Ther; 1989 May; 249(2):638-45. PubMed ID: 2724144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
    Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aflatoxin B1 hydroxylation: sensitive monooxygenase microassay suitable for liver biopsy specimens.
    Krieger RI; Daine K; Hsieh DP; Miller JL; Thongsinthusak T
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):287-96. PubMed ID: 812163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
    van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.